(IBDT) iShares iBonds Dec 2028 - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US46435U5157 • Target Maturity
IBDT: Corporate, Bonds, Investment Grade, Fixed Income, Target Maturity
The iShares iBonds Dec 2028 Term Corporate ETF (IBDT) is designed to track the performance of the Bloomberg Barclays U.S. Corporate Index, focusing on investment-grade corporate bonds maturing between January 1, 2028, and December 15, 2028. The fund invests at least 80% of its assets in securities included in the underlying index and allocates at least 90% to fixed income instruments of the types represented in the index. The index includes U.S. dollar-denominated, investment-grade corporate bonds issued by U.S. and non-U.S. entities, with a minimum outstanding face value of $300 million at the time of inclusion. This structure ensures exposure to a diversified portfolio of corporate debt with a defined maturity range.
Based on the provided data, the 3-month forecast for IBDT suggests continued stability in price movement, supported by its low ATR of 0.14, indicating minimal volatility. The funds average volume of 425,350 shares over the past 20 days reflects moderate liquidity. With its SMA 20, 50, and 200 at 25.13, 25.06, and 24.72, respectively, IBDT is expected to maintain its current price range near 25.31. The funds AUM of $2.787 billion underscores its established presence in the target maturity ETF category, further supporting price stability in the near term.
Additional Sources for IBDT ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
IBDT ETF Overview
Market Cap in USD | 2,788m |
Category | Target Maturity |
TER | 0.10% |
IPO / Inception | 2018-09-18 |
IBDT ETF Ratings
Growth Rating | 16.8 |
Fundamental | - |
Dividend Rating | 72.2 |
Rel. Strength | -3.34 |
Analysts | - |
Fair Price Momentum | 24.65 USD |
Fair Price DCF | - |
IBDT Dividends
Dividend Yield 12m | 4.68% |
Yield on Cost 5y | 5.10% |
Annual Growth 5y | 7.06% |
Payout Consistency | 95.6% |
IBDT Growth Ratios
Growth Correlation 3m | 82.6% |
Growth Correlation 12m | 87.1% |
Growth Correlation 5y | -21% |
CAGR 5y | 1.97% |
CAGR/Max DD 5y | 0.11 |
Sharpe Ratio 12m | 1.86 |
Alpha | 2.71 |
Beta | 0.006 |
Volatility | 3.31% |
Current Volume | 291.2k |
Average Volume 20d | 338.6k |
As of May 09, 2025, the stock is trading at USD 25.16 with a total of 291,219 shares traded.
Over the past week, the price has changed by -0.16%, over one month by +1.15%, over three months by +1.89% and over the past year by +6.95%.
Neither. Based on ValueRay Analyses, iShares iBonds Dec 2028 is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 16.82 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of IBDT as of May 2025 is 24.65. This means that IBDT is currently overvalued and has a potential downside of -2.03%.
iShares iBonds Dec 2028 has no consensus analysts rating.
According to ValueRays Forecast Model, IBDT iShares iBonds Dec 2028 will be worth about 26.6 in May 2026. The stock is currently trading at 25.16. This means that the stock has a potential upside of +5.84%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 26.6 | 5.8% |